Answers are grounded in this paper and cite their sources.
Tumour-targeting and selective ER stress inducers: Small-molecule compounds that target the endoplasmic reticulum (ER) and induce ER stress are emerging as next-generation anticancer agents. This highlight discusses a few current works on this topic and its enormous potential in the fight against cancer.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: